These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 24365257

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer.
    Li X, Huang Y, Fu X, Chen C, Zhang D, Yan L, Xie Y, Mao Y, Li Y.
    Mutagenesis; 2011 May; 26(3):371-83. PubMed ID: 21177315
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Reichardt JK.
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
    [Abstract] [Full Text] [Related]

  • 7. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
    Dušenka R, Tomaškin R, Kliment J, Dobrota D, Dušenková S, Vilčková M, Sivoňová MK.
    Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
    [Abstract] [Full Text] [Related]

  • 8. Polymorphic markers in the 5alpha-reductase type II gene and the incidence of prostate cancer.
    Lamharzi N, Johnson MM, Goodman G, Etzioni R, Weiss NS, Dightman DA, Barnett M, DiTommaso D, Chen C.
    Int J Cancer; 2003 Jul 01; 105(4):480-3. PubMed ID: 12712437
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A49T, V89L and TA repeat polymorphisms of steroid 5alpha-reductase type II and breast cancer risk in Japanese women.
    Yang C, Hamajima N, Iwata H, Saito T, Matsuo K, Hirose K, Inoue M, Takezaki T, Tajima K.
    Breast Cancer Res; 2002 Jul 01; 4(4):R8. PubMed ID: 12100746
    [Abstract] [Full Text] [Related]

  • 12. TA repeat polymorphism of the 5alpha-reductase gene and breast cancer.
    Bharaj B, Scorilas A, Giai M, Diamandis EP.
    Cancer Epidemiol Biomarkers Prev; 2000 Apr 01; 9(4):387-93. PubMed ID: 10794483
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
    Boer H, Westerink NL, Altena R, Nuver J, Dijck-Brouwer DAJ, van Faassen M, Klont F, Kema IP, Lefrandt JD, Zwart N, Boezen HM, Smit AJ, Meijer C, Gietema JA.
    Eur J Cancer; 2016 Feb 01; 54():104-111. PubMed ID: 26751392
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia.
    Hayes VM, Severi G, Padilla EJ, Morris HA, Tilley WD, Southey MC, English DR, Sutherland RL, Hopper JL, Boyle P, Giles GG.
    Int J Cancer; 2007 Feb 15; 120(4):776-80. PubMed ID: 17136762
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.